CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Photo: WS Audiology / PR

Hearing aid manufacturer WS Audiology (WSA) became a reality in 2019 when the merger of Danish company Widex and Sivantos, which was at the time owned by EQT, received final approvals.

Ownership of WSA is now split between EQT and the Tøpholm and Westermann families, the owners of Widex. The families hold 51 percent of the shares while EQT, through a new fund, owns 49 percent of the shares, after EQT sold 4 percent of shares to T&W Medical in January.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs